Minerva Imaging is a contract research organization specializing in molecular imaging services for accelerated and efficient drug development.

We help our clients to reduce the cost and risk of drug development by incorporating preclinical imaging early in the process. In collaboration with our clients we design and conduct tailored molecular imaging protocols to i.e measure drug on target effects, eliminate dead end compounds, and increase the value of lead drug candidates. We facilitate clinical testing and design of adaptive clinical trials using molecular imaging to increase the speed of clinical testing.